Filing Details

Accession Number:
0001209191-14-065633
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-31 18:25:01
Reporting Period:
2014-10-29
Filing Date:
2014-10-31
Accepted Time:
2014-10-31 18:25:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263113 H David Persing C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Chief Med/Tech Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-29 366 $0.00 4,200 No 4 M Direct
Common Stock Disposition 2014-10-29 138 $51.90 4,062 No 4 F Direct
Common Stock Acquisiton 2014-10-30 15,000 $8.43 19,062 No 4 M Direct
Common Stock Disposition 2014-10-30 5,000 $52.55 14,062 No 4 S Direct
Common Stock Disposition 2014-10-30 5,000 $53.07 9,062 No 4 S Direct
Common Stock Disposition 2014-10-30 5,000 $53.60 4,062 No 4 S Direct
Common Stock Acquisiton 2014-10-31 5,000 $8.43 9,062 No 4 M Direct
Common Stock Disposition 2014-10-31 5,000 $54.14 4,062 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2014-10-29 366 $0.00 366 $0.00
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2014-10-30 15,000 $0.00 15,000 $8.43
Common Stock Non-qualified option (right to buy) Disposition 2014-10-31 5,000 $0.00 5,000 $8.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,656 No 4 M Direct
35,000 2016-04-28 No 4 M Direct
30,000 2016-04-28 No 4 M Direct
Footnotes
  1. Vesting of restricted stock units ("RSUs") granted to the Reporting Person.
  2. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares for any reason other than to cover required taxes.
  3. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  5. 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.
  6. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.